S31 Nuclear Regulators in Colitis and Colon Cancer

Program: Symposia
Basic/Translational Session
Friday, March 6, 2015: 9:30 AM-11:00 AM
Room 23 (San Diego Convention Center)
**This session is eligible for CME credit**

Bruce Blumberg, PhD, University of California, Irvine, Irvine, CA

Nothing to Disclose: BB

The incidence of diseases affecting the large bowel (i.e., colon), including inflammatory bowel disease (IBD) and colon cancer is increasing. Several nuclear regulators, such as the PPARs, have been linked with these diseases for some time. A new player on the scene is “orphan” receptor HNF4a, which is best known for its role in the liver and pancreas. This session will explore some of the latest findings about HNF4a in colitis and colon cancer and investigate the role of hypoxia.

9:30 AM
Yatrik Madhukar Shah, PhD, Department of Molecular and Integrative Physiology, Univ of Michigan, Ann Arbor, MI
Nothing to Disclose: YMS
9:50 AM
Karthikeyani Chellappa, PhD, Institute of Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA
Nothing to Disclose: KC
10:10 AM
Michael P Verzi, PhD, Department of Genetics, Rutgers University, Piscataway, NJ
Nothing to Disclose: MPV
See more of: Symposia